New York State Common Retirement Fund Pds Biotechnology Corp Transaction History

New York State Common Retirement Fund

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$2.55 - $4.02 $5,015 - $7,907	-1,967 Reduced 89.78%	224 $1,000
Q1 2024 May 07, 2024	BUY	$3.85 - $6.59 $4,851 - $8,303	1,260 Added 135.34%	2,191 $9,000
Q4 2023 Feb 01, 2024	SELL	$3.95 - $6.58 $63,014 - $104,970	-15,953 Reduced 94.49%	931 $5,000
Q3 2023 Nov 07, 2023	BUY	$4.8 - $6.4 $1,363 - $1,817	284 Added 1.71%	16,884 $85,000
Q2 2023 Aug 07, 2023	BUY	$5.03 - $9.9 $83,498 - $164,340	16,600 New	16,600 $83,000

4.06M

253K

70.4K

Ticker PDSB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,458,700
Market Cap $41.8M
Description
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.